Allergan names new chief financial officer

Allergan has announced the appointment of Matthew Walsh as its new executive vice president and chief financial officer (CFO).

Mr Walsh is an experienced CFO with a strong track record of creating value for shareholders, including 14 years as a CFO with three public companies and ten years working in the healthcare sector as CFO of Catalent.

He will join Allergan later this month following a transition period from his current role with Catalent, where he has led the organisation's transformation under private equity, a successful initial public offering, and numerous acquisition and divestiture transactions.

It is expected that Mr Walsh will deliver a unique combination of skills to Allergan, including a technical background, a deep understanding of the healthcare industry and strong experience across financial disciplines.

Brent Saunders, chairman and chief executive officer at Allergan, said: "I'm pleased to welcome Matt to our team and look forward to partnering with him as we continue to drive strong financial performance and deploy our capital to increase shareholder return over the short and long term."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.